A Study of Doripenem in CerebrospinalFluid After Doripenem Administration in Pediatric Patients Less Than 1 Year of Age
Status:
Terminated
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize the penetration of doripenem in the cerebral
spinal fluid in pediatric patients <1 year of age who are hospitalized and have a documented
or suspected infection and are planning to, or undergoing treatment with intravenous (IV)
antibiotics.